The Novavax vaccine is 89% effective against COVID-19 in a UK study, but less so against the South African variant; the actions skyrocket
Novavax stock soars more than 20% after COVID-19 vaccine study shows almost 90% effectiveness in the UK, but less against the new South African variant
